Cargando…
Fisetin is a senotherapeutic that extends health and lifespan
BACKGROUND: Senescence is a tumor suppressor mechanism activated in stressed cells to prevent replication of damaged DNA. Senescent cells have been demonstrated to play a causal role in driving aging and age-related diseases using genetic and pharmacologic approaches. We previously demonstrated that...
Autores principales: | Yousefzadeh, Matthew J., Zhu, Yi, McGowan, Sara J., Angelini, Luise, Fuhrmann-Stroissnigg, Heike, Xu, Ming, Ling, Yuan Yuan, Melos, Kendra I., Pirtskhalava, Tamar, Inman, Christina L., McGuckian, Collin, Wade, Erin A., Kato, Jonathon I., Grassi, Diego, Wentworth, Mark, Burd, Christin E., Arriaga, Edgar A., Ladiges, Warren L., Tchkonia, Tamara, Kirkland, James L., Robbins, Paul D., Niedernhofer, Laura J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197652/ https://www.ncbi.nlm.nih.gov/pubmed/30279143 http://dx.doi.org/10.1016/j.ebiom.2018.09.015 |
Ejemplares similares
-
New agents that target senescent cells: the flavone, fisetin, and the BCL-X(L) inhibitors, A1331852 and A1155463
por: Zhu, Yi, et al.
Publicado: (2017) -
Targeting cellular senescence with novel senotherapeutics by design to extend healthspan
por: Zhang, Lei, et al.
Publicado: (2021) -
FUCOIDANS ARE NOVEL SENOTHERAPEUTICS THAT ENHANCE SIRT6 AND DNA REPAIR ACTIVITY
por: Zhang, Lei, et al.
Publicado: (2022) -
FUCOIDANS ARE NOVEL SENOTHERAPEUTICS THAT ENHANCE SIRT6 AND DNA REPAIR ACTIVITY
por: Zhang, Lei, et al.
Publicado: (2022) -
Effect of Combined Dasatinib and Fisetin Treatment on Senescent Cell Clearance in Monkeys
por: Colman, Ricki, et al.
Publicado: (2020)